HK1039060B - 用於提高突觸應答的酰基苯並噁嗪 - Google Patents

用於提高突觸應答的酰基苯並噁嗪

Info

Publication number
HK1039060B
HK1039060B HK02100196.0A HK02100196A HK1039060B HK 1039060 B HK1039060 B HK 1039060B HK 02100196 A HK02100196 A HK 02100196A HK 1039060 B HK1039060 B HK 1039060B
Authority
HK
Hong Kong
Prior art keywords
ampa receptors
enhancing
treatment
methods
acylbenzoxazines
Prior art date
Application number
HK02100196.0A
Other languages
English (en)
Other versions
HK1039060A1 (en
Inventor
加里‧A‧羅杰斯
彼得‧約翰斯特羅姆
Original Assignee
加利福尼亞大學董事會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 加利福尼亞大學董事會 filed Critical 加利福尼亞大學董事會
Publication of HK1039060A1 publication Critical patent/HK1039060A1/xx
Publication of HK1039060B publication Critical patent/HK1039060B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK02100196.0A 1998-04-03 2002-01-11 用於提高突觸應答的酰基苯並噁嗪 HK1039060B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,916 US6124278A (en) 1998-04-03 1998-04-03 Acylbenzoxazines for enhancing synaptic response
PCT/US1999/007325 WO1999051240A1 (en) 1998-04-03 1999-04-02 Acylbenzoxazines for enhancing synaptic response(s)

Publications (2)

Publication Number Publication Date
HK1039060A1 HK1039060A1 (en) 2002-04-12
HK1039060B true HK1039060B (zh) 2005-05-13

Family

ID=21994357

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100196.0A HK1039060B (zh) 1998-04-03 2002-01-11 用於提高突觸應答的酰基苯並噁嗪

Country Status (22)

Country Link
US (1) US6124278A (zh)
EP (1) EP1067935B1 (zh)
JP (1) JP4574846B2 (zh)
KR (1) KR100646753B1 (zh)
CN (1) CN1186020C (zh)
AT (1) ATE247472T1 (zh)
BR (1) BR9909378A (zh)
CA (1) CA2326764C (zh)
CZ (1) CZ292931B6 (zh)
DE (1) DE69910552T2 (zh)
DK (1) DK1067935T3 (zh)
ES (1) ES2207194T3 (zh)
HK (1) HK1039060B (zh)
HU (1) HUP0102321A3 (zh)
IL (1) IL138284A0 (zh)
NO (1) NO20004383L (zh)
NZ (1) NZ506712A (zh)
PL (1) PL195394B1 (zh)
PT (1) PT1067935E (zh)
RU (1) RU2246498C2 (zh)
TR (1) TR200002849T2 (zh)
WO (1) WO1999051240A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
NZ529671A (en) 2001-06-14 2005-10-28 Akzo Nobel Nv (Pyrido/thieno)-[f]-oxazepin-5-one derivatives
MXPA04004815A (es) * 2001-11-26 2005-02-17 Cortex Pharma Inc Compuestos de carbonilbenzoxazina para mejorar respuestas sinapticas, glutamatergicas.
EP2173369A2 (en) * 2003-08-08 2010-04-14 DSM IP Assets B.V. Novel method for screening brain-active compounds
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
CN102056922B (zh) * 2008-06-06 2013-11-20 赛诺菲-安万特 作为tafia抑制剂的大环脲和磺酰胺衍生物
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders
CN108689876B (zh) * 2018-06-28 2020-11-27 苏州东南药业股份有限公司 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
NZ255097A (en) * 1992-07-24 2001-04-27 Univ California Heterocyclic derivatives (such as 1-(1,4-bgenzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine) and medicaments that enhance synaptic responses
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response

Also Published As

Publication number Publication date
CA2326764A1 (en) 1999-10-14
DK1067935T3 (da) 2003-11-24
PT1067935E (pt) 2004-01-30
JP4574846B2 (ja) 2010-11-04
ES2207194T3 (es) 2004-05-16
JP2002510635A (ja) 2002-04-09
HUP0102321A3 (en) 2002-01-28
RU2246498C2 (ru) 2005-02-20
CA2326764C (en) 2010-12-14
IL138284A0 (en) 2001-10-31
NO20004383L (no) 2000-10-09
AU736376B2 (en) 2001-07-26
WO1999051240A1 (en) 1999-10-14
PL195394B1 (pl) 2007-09-28
CN1306427A (zh) 2001-08-01
HUP0102321A2 (hu) 2001-11-28
AU3379899A (en) 1999-10-25
ATE247472T1 (de) 2003-09-15
CN1186020C (zh) 2005-01-26
EP1067935A4 (en) 2001-10-04
CZ292931B6 (cs) 2004-01-14
EP1067935B1 (en) 2003-08-20
PL345687A1 (en) 2002-01-02
NO20004383D0 (no) 2000-09-04
DE69910552D1 (de) 2003-09-25
WO1999051240A8 (en) 2001-03-22
US6124278A (en) 2000-09-26
CZ20003614A3 (cs) 2001-01-17
TR200002849T2 (tr) 2001-06-21
KR100646753B1 (ko) 2006-11-17
EP1067935A1 (en) 2001-01-17
BR9909378A (pt) 2000-12-05
DE69910552T2 (de) 2004-06-17
KR20010042192A (ko) 2001-05-25
NZ506712A (en) 2002-11-26
HK1039060A1 (en) 2002-04-12

Similar Documents

Publication Publication Date Title
AU2427497A (en) Benzoxazines for enhancing synaptic response
CA2138533A1 (en) Drugs that enhance synaptic responses mediated by ampa receptors
PL323667A1 (en) Benzoylopiperidines/benzoylopyrolydines for amplifying synaptic response
IL136783A (en) Synaptic response enhancing benzoxazine compounds,their preparation and pharmaceutical compositions containing them
WO1996018738A3 (en) PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
IL138284A0 (en) Acylbenzoxazines for enhancing synaptic response(s)
PL316313A1 (en) Naphtyloamides as agents acting on a central nerve system
CA2279319A1 (en) Benzofurazan compounds which enhance ampa receptor activity
EA200400584A1 (ru) Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120402